Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis.
<h4>Background</h4>Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (NERD) might benefit from aspirin desensitization (AD) as an alternative treatment to standard care. However, there is conflicting evidence regarding its role in bronchial symptoms and asthma exacerbat...
Main Authors: | Isabel Eraso, Saveria Sangiovanni, Eliana I Morales, Liliana Fernández-Trujillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247871&type=printable |
Similar Items
-
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
by: Dorien Van Broeck, et al.
Published: (2023-04-01) -
A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization
by: Hossein Esmaeilzadeh, et al.
Published: (2022-10-01) -
Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
by: Tanya M. Laidlaw
Published: (2018-09-01) -
The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
by: Tran Locke, et al.
Published: (2020-12-01) -
Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases
by: Julio César Cambray-Gutiérrez, et al.
Published: (2016-05-01)